To better characterize the contribution of ZnT1 in ALS, we evaluated the effects of silencing ZnT1 in differentiated NSC-34 ​cells exposed to the neurotoxin L-BMAA. This evidence concerns the gene SLC30A1 and amyotrophic lateral sclerosis.